Tenax Therapeutics Statistics
NASDAQ: TENXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.25-0.14 (-10.07%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Tenax Therapeutics by the numbers
Tenax Therapeutics has a market capitalization of $56.9 million based on 45.54M shares outstanding. With trailing EPS of $-1.39, Tenax Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.0% below its 50-day average and 86.3% below its 200-day average.
Average daily trading volume is 3.15M shares, or about $3.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TENX valuation vs. peer median
| Metric | TENX | Peer median | Difference |
|---|---|---|---|
| Market cap | $56.92M | $54.89M | +4% |
| Avg. volume | 3.15M | 122.68K | +2470% |
Peer median across 8 companies: IBIO, KZIA, AZR, RANI, BOLD, XLO, CTOR, XBIT.
Valuation
- Market cap
- $56.92M
- EPS (TTM)
- $-1.39
- Shares outstanding
- 45.54M
Price and trading
- Previous close
- 1.39
- Open
- 1.32
- Day range
- 1.24 – 1.35
- 52-week range
- 1.24 – 19.40
- 52-week change
- -84.66%
- Beta
- —
- Volume
- 2.28M
- Average volume
- 3.15M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 56.92M
- Forward Pe
- -0.96
- Eps
- -1.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.40
- Week52 Low
- 1.24
- Avg Volume
- 3.15M
- Shares Outstanding
- 45.54M
- Ma50
- 1.74
- Ma200
- 9.12
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -93.56%
- Pct From52w Low
- 0.81%